The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
The Sentinel Within: Exploiting the Immune System for Cancer Biomarkers
Open accessAbstract
The release of proteins from tumors triggers an immune response in cancer patients. These tumor antigens arise from several mechanisms including tumor-specific alterations in protein expression, mutation, folding, degradation, or intracellular localization. Responses to most tumor antigens are rarely observed in healthy individuals, making the response itself a biomarker that betrays the presence of underlying cancer. Antibody immune responses show promise as clinical biomarkers because antibodies have long half-lives in serum, are easy to measure, and are stable in blood samples. However, our understanding of the specificity and the impact of the immune response in early stages of cancer is limited. The immune response to cancer, whether endogenous or driven by vaccines, involves highly specific T lymphocytes (which target tumor-derived peptides bound to self-MHC proteins) and B lymphocytes (which generate antibodies to tumor-derived proteins). T cell target antigens have been identified either by expression cloning from tumor cDNA libraries, or by prediction based on patterns of antigen expression ("reverse immunology"). B cell targets have been similarly identified using the antibodies in patient sera to screen cDNA libraries derived from tumor cell lines. This review focuses on the application of recent advances in proteomics for the identification of tumor antigens. These advances are opening the door for targeted vaccine development, and for using immune response signatures as biomarkers for cancer diagnosis and monitoring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V, Hamada, H., Pardoll, D., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,818
SYFPEITHI: database for MHC ligands and peptide motifs
Rammensee, H. G., Bachmann, J., Emmerich, N. P. N., Bachor, O. A., & Stevanović, S. (1999) · Immunogenetics · doi:10.1007/s002510050595 · Cited by 2,314
SPECIFIC CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEM
Gold, P., & Freedman, S. O. (1965) · The Journal of Experimental Medicine · doi:10.1084/jem.122.3.467 · Cited by 1,879
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
Schubert, U., Antón, L. C., Gibbs, J., Norbury, C. C., Yewdell, J. W., & Bennink, J. R. (2000) · Nature · doi:10.1038/35008096 · Cited by 1,536
Cloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 Receptor
Grabstein, K. H., Eisenman, J., Shanebeck, K., Rauch, C., Srinivasan, S., Fung, V., Beers, C., Richardson, J., Schoenborn, M. A., Ahdieh, M., et al. (1994) · Science · doi:10.1126/science.8178155 · Cited by 1,422
Parker, K. C., Bednarek, M. A., & Coligan, J. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.1.163 · Cited by 1,370
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
Chen, Y.-T., Scanlan, M. J., Sahin, U., Türeci, Ö., Gure, A. O., Tsang, S., Williamson, B., Stockert, E., Pfreundschuh, M., & Old, L. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1914 · Cited by 1,247
Characterization of Peptides Bound to the Class I MHC Molecule HLA-A2.1 by Mass Spectrometry
Hunt, D. F., Henderson, R. A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A. L., Appella, E., & Engelhard, V. H. (1992) · Science · doi:10.1126/science.1546328 · Cited by 1,198
Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
Huang, A. Y. C., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., & Levitsky, H. (1994) · Science · doi:10.1126/science.7513904 · Cited by 1,160
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy
Scanlan., M. J., Gure., A. O., Jungbluth., A. A., Old., L. J., & Chen., Y. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18803.x · Cited by 873
Purification of a Human Prostate Specific Antigen
Wang, M. C., Valenzuela, L. A., Murphy, G. P., & Chu, T. M. (2017) · Journal of Urology · doi:10.1016/j.juro.2016.10.100 · Cited by 825
DeLeo, A. B., Jay, G., Appella, E., Dubois, G. C., Law, L. W., & Old, L. J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.5.2420 · Cited by 721
A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens
Stockert, E., Jäger, E., Chen, Y.-T., Scanlan, M. J., Gout, I., Karbach, J., Arand, M., Knuth, A., & Old, L. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1349 · Cited by 698
Autoantigen microarrays for multiplex characterization of autoantibody responses
Robinson, W. H., DiGennaro, C., Hueber, W., Haab, B. B., Kamachi, M., Dean, E. J., Fournel, S., Fong, D., Genovese, M. C., De Vegvar, H. E. N., et al. (2002) · Nature Medicine · doi:10.1038/nm0302-295 · Cited by 673
Molldrem, J. J., Lee, P. P., Wang, C., Felio, K., Kantarjian, H. M., Champlin, R. E., & Davis, M. M. (2000) · Nature Medicine · doi:10.1038/79526 · Cited by 672
Templin, M. F., Stoll, D., Schrenk, M., Traub, P. C., Vöhringer, C. F., & Joos, T. O. (2002) · Trends in Biotechnology · doi:10.1016/s0167-7799(01)01910-2 · Cited by 572
Vonderheide, R. H., Hahn, W. C., Schultze, J. L., & Nadler, L. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80066-7 · Cited by 570
p53 Antibodies in the sera of patients with various types of cancer: a review.
Soussi, T. (2000) · PubMed · Cited by 550
Self-Assembling Protein Microarrays
Ramachandran, N., Hainsworth, E., Bhullar, B., Eisenstein, S., Rosen, B., Lau, A. Y., Walter, J. C., & LaBaer, J. (2004) · Science · doi:10.1126/science.1097639 · Cited by 548
Self-citationHLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides
Wei, M. L., & Cresswell, P. (1992) · Nature · doi:10.1038/356443a0 · Cited by 496
Cleavage by Granzyme B Is Strongly Predictive of Autoantigen Status
Casciola-Rosen, L., Andrade, F., Ulanet, D., Wong, W. B., & Rosen, A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.6.815 · Cited by 492
Davis, I. D., Chen, W., Jackson, H., Parente, P., Shackleton, M., Hopkins, W., Chen, Q., Dimopoulos, N., Luke, T., Murphy, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403572101 · Cited by 440
The major substrates for TAP in vivo are derived from newly synthesized proteins
Reits, E. A. J., Vos, J. C., Grommé, M., & Neefjes, J. (2000) · Nature · doi:10.1038/35008103 · Cited by 415
Trends in biomarker research for cancer detection
Srinivas, P. R., Kramer, B. S., & Srivastava, S. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00560-5 · Cited by 411
Lack of a Fusion Requirement for Development of Bone Marrow-Derived Epithelia
Harris, R. G., Herzog, E. L., Bruscia, E. M., Grove, J. E., Van Arnam, J. S., & Krause, D. S. (2004) · Science · doi:10.1126/science.1098925 · Cited by 407
Reche, P., Glutting, J.-P., Zhang, H., & Reinherz, E. (2004) · Immunogenetics · doi:10.1007/s00251-004-0709-7 · Cited by 386
Disis, M. L., Pupa, S. M., Gralow, J. R., Dittadi, R., Menard, S., & Cheever, M. A. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.11.3363 · Cited by 345
Characterization of human colon cancer antigens recognized by autologous antibodies
Scanlan, M. J., Chen, Y.-T., Williamson, B., Gure, A. O., Stockert, E., Gordan, J. D., Türeci, Ö., Sahin, U., Pfreundschuh, M., & Old, L. J. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980529)76:5<652::aid-ijc7>3.0.co;2-p · Cited by 339
Post-translational protein modifications in antigen recognition and autoimmunity
Doyle, H. A., & Mamula, M. J. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01976-7 · Cited by 280
CA125 antigen levels in obstetric and gynecologic patients.
Niloff, J. M., KNAPP, R. C., Schaetzl, E., Reynolds, C., & Bast, R. C. (1984) · PubMed · Cited by 271
Odunsi, K. O., Jungbluth, A. A., Stockert, E., Qian, F., Gnjatic, S., Tammela, J., Intengan, M., Beck, A. F., Keitz, B. T., Santiago, D., et al. (2003) · PubMed · Cited by 249
Protein microarrays: Promising tools for proteomic research
Templin, M. F., Stoll, D., Schwenk, J. M., Pötz, O., Kramer, S., & Joos, T. O. (2003) · PROTEOMICS · doi:10.1002/pmic.200300600 · Cited by 244
Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.
Zhang, J.-Y., Casiano, C. A., Peng, X.-X., et al. (2003) · PubMed · Cited by 244
MHCPEP, a database of MHC-binding peptides: update 1997
Brusic, V (1998) · Nucleic Acids Research · doi:10.1093/nar/26.1.368 · Cited by 242
SSX: A multigene family with several members transcribed in normal testis and human cancer
Gure, A. O., Türeci, Ö., Şahin, U., Tsang, S., Scanlan, M. J., Jäger, E., Knuth, A. K., Pfreundschuh, M. G., Old, L. J., & Chen, Y. (1997) · International Journal of Cancer · Cited by 239
Güre, A. O., Stockert, E., Scanlan, M. J., Keresztes, R. S., Jäger, D., Altorki, N. K., Old, L. J., & Chen, Y.-T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4198 · Cited by 234
Jäger, E., Stockert, E., Zidianakis, Z., Chen, Y.-T., Karbach, J., Jäger, D., Arand, M., Ritter, G., Old, L. J., & Knuth, A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991022)84:5<506::aid-ijc10>3.0.co;2-6 · Cited by 227
Characterization of Naturally Occurring Minor Histocompatibility Peptides Including H-4 and H-Y
Rötzschke, O., Falk, K., Wallny, H.-J., Faath, S., & Rammensee, H.-G. (1990) · Science · doi:10.1126/science.1695760 · Cited by 214
Casey, G., Me, L., Jc, R., Sj, P., Arboleda, M. J., Shaughnessy, M., Karlan, B. Y., & Dj, S. (1996) · PubMed · Cited by 205
Pavlenko, M., Roos, A.-K., Lundqvist, A., Palmborg, A., Miller, A. M., Ozenci, V, Bergman, B., Egevad, L., Hellström, M., Kiessling, R., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602019 · Cited by 195
Proteolytic processing and physiological regulation
Neurath, H. (1989) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(89)90061-3 · Cited by 194
Integrated functional genomics approach for the design of patient-individual antitumor vaccines.
Weinschenk, T., Gouttefangeas, C., Schirle, M., Obermayr, F., Walter, S., Schoor, O., Kurek, R., Loeser, W., Bichler, K., Wernet, D., et al. (2002) · PubMed · Cited by 190
The autoantibody repertoire: searching for order
Plotz, P. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri976 · Cited by 187
Scanlan, M. J., Gout, I. T., Gordon, C., Williamson, B., Stockert, E., Gure, A. O., Jäger, D., Chen, Y., Mackay, A. G., O'Hare, M. J., et al. (2001) · PubMed · Cited by 182
Scanlan, M. J., Welt, S., Gordon, C., Chen, Y., Gure, A. O., Stockert, E., Jungbluth, A. A., Ritter, G., Jäger, D., Jäger, E., et al. (2002) · PubMed · Cited by 180
Antigens recognized by autologous antibody in patients with renal-cell carcinoma
Scanlan, M. J., Gordan, J. D., Williamson, B., Stockert, E., Bander, N. H., Jongeneel, C. V., Gure, A. O., J�ger, D., J�ger, E., Knuth, A. K., et al. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991112)83:4<456::aid-ijc4>3.0.co;2-5 · Cited by 177
Zorn, E., Miklos, D. B., Floyd, B. H., Mattes-Ritz, A., Guo, L., Soiffer, R. J., Antin, J. H., & Ritz, J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031560 · Cited by 175
Recursive partitioning as an approach to selection of immune markers for tumor diagnosis.
Koziol, J. A., Zhang, J.-Y., Casiano, C. A., Peng, X.-X., Shi, F., Feng, A. C., Chan, E. K. L., & Tan, E. M. (2003) · PubMed · Cited by 164
Disis, M. L., Knutson, K. L., Schiffman, K., Rinn, K., & McNeel, D. G. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006438507898 · Cited by 159
Principles and Practice of the Biologic Therapy of Cancer
Rosenberg, S. A. (2000) · Cited by 147
Scanlan, M. J., Altorki, N. K., Gure, A. O., Williamson, B., Jungbluth, A. A., Chen., Y., & Old, L. J. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00385-7 · Cited by 140
Kao, H., Marto, J. A., Hoffmann, T. K., Shabanowitz, J., Finkelstein, S. D., Whiteside, T. L., Hunt, D. F., & Finn, O. J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.9.1313 · Cited by 138
Identification of cancer/testis genes by database mining and mRNA expression analysis
Scanlan, M. J., Gordon, C., Williamson, B., Lee, S., Chen, Y., Stockert, E., Jungbluth, A. A., Ritter, G., Jäger, D., Jäger, E., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10276 · Cited by 138
Jäger, D., Stockert, E., Gure, A. O., Scanlan, M. J., Karbach, J., Jäger, E., Knuth, A. K., Old, L. J., & Chen, Y. (2001) · PubMed · Cited by 131
Expression of cancer/testis (CT) antigens in lung cancer
Tajima, K., Obata, Y., Tamaki, H., Yoshida, M., Chen, Y., Scanlan, M. J., Old, L. J., Kuwano, H., Takahashi, T., Takahashi, T., et al. (2003) · Lung Cancer · doi:10.1016/s0169-5002(03)00244-7 · Cited by 131
Trivers, G. E., Benedetti, V. M. D., Cawley, H., Caron, G., Harrington, A. M., Bennett, W. P., Jett, J. R., Colby, T. V., Tazelaar, H. D., Pairolero, P. C., et al. (1996) · PubMed · Cited by 128
Qiu, J., Madoz‐Gúrpide, J., Misek, D. E., Kuick, R. D., Brenner, D. E., Michailidis, G. C., Haab, B. B., Omenn, G. S., & Hanash, S. (2004) · Journal of Proteome Research · doi:10.1021/pr049971u · Cited by 122
Gure, A. O., Stockert, E., Arden, K. C., Boyer, A. D., Viars, C. S., Scanlan, M. J., Old, L. J., & Chen, Y. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000301)85:5<726::aid-ijc21>3.0.co;2-f · Cited by 121
Ishikawa, T., Fujita, T., Suzuki, Y., Okabe, S., Yuasa, Y., Iwai, T., & Kawakami, Y. (2003) · PubMed · Cited by 117
Clinical Proteomics: Revolutionizing Disease Detection and Patient Tailoring Therapy
Petricoin, E. F., Wulfkuhle, J. D., Espina, V. A., & Liotta, L. A. (2004) · Journal of Proteome Research · doi:10.1021/pr049972m · Cited by 114
Immunomic analysis of human sarcoma
Lee, S., Obata, Y., Yoshida, M., Stockert, E., Williamson, B., Jungbluth, A. A., Chen, Y., Old, L. J., & Scanlan, M. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437972100 · Cited by 113
Suzuki, H., Graziano, D. F., McKolanis, J., & Finn, O. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0538 · Cited by 113
Genome-wide Characterization of a Viral Cytotoxic T Lymphocyte Epitope Repertoire
Zhong, W., Reche, P. A., Lai, C., Reinhold, B. B., & Reinherz, E. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307417200 · Cited by 111
Clinical utility of the immunocytochemical detection of p53 protein in cytological specimens.
Dowell, S. P., Wilson, P., Derias, N. W., Lane, D. P., & Hall, P. A. (1994) · PubMed · Cited by 110
Miniaturised multiplexed immunoassays
Joos, T. O., Stoll, D., & Templin, M. F. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(01)00289-7 · Cited by 106
Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer
Fernández-Madrid, F., Tang, N., Alansari, H., Granda, J. L., Tait, L. R., Amirikia, K. C., Moroianu, M., Wang, X., & Karvonen, R. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0932 · Cited by 106
Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction
Schmollinger, J. C., Vonderheide, R. H., Hoar, K. M., Maecker‐Kolhoff, B., Schultze, J. L., Hodi, F. S., Soiffer, R. J., Jung, K., Kuroda, M. J., Letvin, N. L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530311100 · Cited by 105
Gillessen, S., Naumov, Y. N., Nieuwenhuis, E. E. S., Exley, M. A., Lee, F. S., Mach, N., Luster, A. D., Blumberg, R. S., Taniguchi, M., Balk, S. P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1033098100 · Cited by 100
Characterisation of tumour-associated antigens in colon cancer
Linē, A., Kalniņa, Z., Stengrēvics, A., Siliņa, K., Li, G., & Rees, R. C. (2002) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-002-0322-2 · Cited by 94
Stoll, D. (2002) · Frontiers in bioscience · doi:10.2741/stoll · Cited by 93
(2004) · Focus on Surfactants · doi:10.1016/s1351-4210(04)00169-6 · Cited by 91
Raben, N., Nichols, R., Dohlman, J. G., McPhie, P., Sridhar, V., Hyde, C., Leff, R. L., & Plotz, P. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51078-x · Cited by 90
CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.
Yang, X., Wu, C. J., Chen, L., Alyea, E. P., Canning, C. M., Kantoff, P. W., Soiffer, R. J., Dranoff, G., & Ritz, J. (2002) · PubMed · Cited by 90
Post-translational modifications of proteins: some problems left to solve
Yan, S. C. B., Grinnell, B. W., & Wold, F. (1989) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(89)90060-1 · Cited by 87
Minenkova, O., Pucci, A., Pavoni, E., Tomassi, A. D., Fortugno, P., Gargano, N., Cianfriglia, M., Barca, S., Placido, S. D., Martignetti, A., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11269 · Cited by 87
Towards patient‐specific tumor antigen selection for vaccination
Rammensee, H., Weinschenk, T., Gouttefangeas, C., & Eq, S. S. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18815.x · Cited by 84
Posttranslational protein modifications: new flavors in the menu of autoantigens
Doyle, H. A., & Mamula, M. J. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200205000-00009 · Cited by 83
Bouwman, K., Qiu, J., Zhou, H., Schotanus, M. P., Mangold, L. A., Vogt, R. F., Erlandson, E. J., Trenkle, J. M., Partin, A. W., Misek, D. E., et al. (2003) · PROTEOMICS · doi:10.1002/pmic.200300611 · Cited by 78
Bellucci, R., Wu, C. J., Chiaretti, S., Weller, E. A., Davies, F. E., Alyea, E. P., Dranoff, G., Anderson, K. C., Munshi, N. C., & Ritz, J. (2003) · Blood · doi:10.1182/blood-2003-07-2559 · Cited by 75
Self-citationAntigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine
Chang, E. Y., Chen, C., Ji, H., Wang, T., Hung, K. E., Lee, B. P., Huang, A. Y.-C., Kurman, R. J., Pardoll, D. M., & Wu, T. ‐. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000601)86:5<702::aid-ijc16>3.0.co;2-1 · Cited by 74
Immunotherapy of Hematologic Malignancy
Heslop, H. E., Stevenson, F. K., & Molldrem, J. J. (2003) · Hematology · doi:10.1182/asheducation-2003.1.331 · Cited by 74
Protein arrays for autoantibody profiling and fine‐specificity mapping
Robinson, W. H., Steinman, L., & Utz, P. J. (2003) · PROTEOMICS · doi:10.1002/pmic.200300583 · Cited by 73
The 72-kDa Component of Signal Recognition Particle Is Cleaved during Apoptosis
Utz, P. J., Hottelet, M., Le, T. M., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35362 · Cited by 69
Rodolfo, M., Luksch, R., Stockert, E., Chen, Y., Collini, P., Ranzani, T., Lombardo, C., Dalerba, P. D., Rivoltini, L., Arienti, F., et al. (2003) · PubMed · Cited by 67
Fosså, A., Alsøe, L., Crameri, R., Funderud, S., Gaudernack, G., & Smeland, E. B. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0458-8 · Cited by 66
Ulanet, D., Torbenson, M. S., Dang, C. V., Casciola-Rosen, L. A., & Rosen, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2035245100 · Cited by 64
The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases
Routsias, J. G., Tzioufas, A. G., & Moutsopoulos, H. Μ. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.10.011 · Cited by 64
Series Introduction: Autoimmune diseases: are markers ready for prediction?
Lernmark, Å. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200114234 · Cited by 64
Humoral immune response against p53 protein in patients with colorectal carcinoma
Angelopoulou, K., Stratis, M., & Diamandis, E. P. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970106)70:1<46::aid-ijc7>3.0.co;2-6 · Cited by 62
Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries
Sioud, M., & Hansen, M. H. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200103)31:3<716::aid-immu716>3.0.co;2-9 · Cited by 61
DiFronzo, L. A., Gupta, R. K., Essner, R., Foshag, L. J., O'Day, S. J., Wanek, L. A., Stern, S. L., & Morton, D. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.01.065 · Cited by 58
Jäger, D., Unkelbach, M. H., Frei, C., et al. (2002) · PubMed · Cited by 55
Experimental evidence for an alternative to directed mutation in thebgl operon
Mittler, J., & Lenski, R. (1992) · Nature · doi:10.1038/356446a0 · Cited by 51
ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction
Hodi, F. S., Schmollinger, J. C., Soiffer, R. J., Salgia, R., Lynch, T. J., Ritz, J., Alyea, E. P., Yang, J., Neuberg, D. S., Mihm, M. C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102025999 · Cited by 49
Mischo, A., Wadle, A., Wätzig, K., Jäger, D., Stockert, E., Santiago, D., Ritter, G., Regitz, E., Jäger, E., Knuth, A., et al. (2003) · PubMed · Cited by 43
An immunodominant SSX-2–derived epitope recognized by CD4+ T cells in association with HLA-DR
Ayyoub, M., Hesdorffer, C. S., Montes, M., Merlo, A. C., Speiser, D. E., Rimoldi, D., Cerottini, J., Ritter, G., Scanlan, M. J., Old, L. J., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20667 · Cited by 40
Proteomics Approaches to Uncover the Repertoire of Circulating Biomarkers for Breast Cancer
Shin, B. K., Wang, H., & Hanash, S. (2002) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1024038132381 · Cited by 39
Isoforms of the human PDZ-73 protein exhibit differential tissue expression
Scanlan, M. J., Williamson, B., Jungbluth, A. A., Stockert, E., Arden, K. C., Viars, C. S., Gure, A. O., Gordan, J. D., Chen, Y., & Old, L. J. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00033-0 · Cited by 37
The use of HPLC-MS in T-cell epitope identification
Lemmel, C. (2003) · Methods · doi:10.1016/s1046-2023(02)00347-x · Cited by 32
Shimada, H. (2001) · The European Journal of Surgery · doi:10.1080/110241501750069828 · Cited by 32
Ehlken, H., Schadendorf, D., & Eichmüller, S. B. (2003) · International Journal of Cancer · doi:10.1002/ijc.11537 · Cited by 26
Absence of p53 autoantibodies in sera from glioma patients.
Rainov, N. G., Dobberstein, K.-U., Fittkau, M., Bahn, H., Holzhausen, H. ‐., Gantchev, L. S., & Burkert, W. L. (1995) · PubMed · Cited by 23
Humoral immune response to p53 in malignant glioma
Weller, M., Ständer, M., Schabet, M., DICHGANS, J., Bornemann, A., & Meyermann, R. (1998) · Journal of Neurology · doi:10.1007/s004150050199 · Cited by 16
Cited by
Serum autoantibodies as biomarkers for early cancer detection
Tan, H. T., Low, J., Lim, S. G., & Chung, M. C. M. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07396.x · Cited by 315
Autoantibodies to tumor‐associated antigens: reporters from the immune system
Tan, E. M., & Zhang, J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00611.x · Cited by 309
Zaenker, P., Gray, E. S., & Ziman, M. R. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.01.017 · Cited by 267
Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes
Wandall, H. H., Blixt, O., Tarp, M. A., Pedersen, J. W., Bennett, E. P., Mandel, U., Ragupathi, G., Livingston, P. O., Hollingsworth, M. A., Taylor-Papadimitriou, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2893 · Cited by 266
Hudson, M. E., Pozdnyakova, I., Haines, K., Mor, G., & Snyder, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708572104 · Cited by 261
Metadata
- Authors
- Anderson, K. S., & LaBaer, J.
- Venue
- Journal of Proteome Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2005-06-18
- Volume
- 4
- Issue
- 4
- Pages
- 1123-1133
- ISSN
- 1535-3893 (ISSN-L)
- 1535-3907
- OpenAlex
- W2157533109
- Cited by
- 314
- References
- 104
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.